FoRx Therapeutics

Series-A
forxtherapeutics.com Biotech & Healthcare Basel, Switzerland Founded 2019 11-50
Total Funding $60.9M
Latest Round $50M Series-A
Last Announced Dec 18, 2025
Investors 5 Backers
Decision Makers 4 Verified

About FoRx Therapeutics

Next-Generation Therapeutics FoRx Therapeutics is a privately held clinical-stage biotechnology company pioneering precision therapeutics targeting DNA Replication Stress in treatment-resistant cancers.

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-A
Global Headquarters Basel, Switzerland
Year Founded 2019
Team Size 11-50
Tracked Since Oct 1, 2026

Web & Domain Identity

Official Website forxtherapeutics.com
Domain Registered Date Nov 19, 2019

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Not linked

Company Milestones & Timeline

4 Events
  1. Capital Raise

    Raised $50,000,000 · Series-A

    fundraisingfox.com

  2. Capital Raise

    Raised $10,867,000 · Seed

  3. Milestone

    Website domain registered

    forxtherapeutics.com

  4. Milestone

    Company founded

    Basel, Switzerland

Investors & Backers

5
EQT Life Sciences
M Ventures
Novartis Venture Fund
Omega Funds
Pfizer Venture Investments

Funding History

2 Rounds
Series-A · Dec 18, 2025
Seed · Apr 22, 2020
$10,867,000 Source

Founders & Leadership

3

Sotirios Sotiriou

Founder

Work email & phone locked Unlock →

Tarig Bashir

Chief Executive Officer

Work email & phone locked Unlock →

Thanos Halazonetis

Founder

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts